• Huong McLean PhD, MPH

  • Research Scientist

    • Center for Clinical Epidemiology & Population Health
    • 1000 North Oak Ave. ML2 Marshfield, WI 54449


PhD, Epidemiology, University of Washington, Seattle, WA
MPH, Epidemiology, University of Minnesota, Minneapolis, MN
BA, Chemistry, College of Saint Benedict, Saint Joseph, MN

Work Experience

2017 to Present:
Research Scientist, Marshfield Clinic Research Institute, Marshfield, WI
2012 to 2017:
Associate Research Scientist, Marshfield Clinic Research Institute, Marshfield, WI
2008 to 2012:
Epidemiologist, Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA
2004 to 2008:
Pre-doctoral Research Associate, Department of Epidemiology, Virology Research Clinic, University of Washington, Seattle, WA
2002 to 2004:
Research Fellow, National Immunization Program, Centers for Disease Control and Prevention, Associations of Schools of Public Health, Atlanta, GA


Dr. McLean is an epidemiologist with focus on infectious diseases and vaccine effectiveness, immunogenicity, safety, and policy. Much of her research activities are focused on influenza, addressing issues relating to prior vaccination history and vaccine effectiveness, both clinically and immunologically. Her research also includes promoting adolescent vaccinations, including human papillomavirus (HPV) vaccine and examining long-term immunogencity of measles, mumps, rubella (MMR) vaccine.
She directs the MCRI Summer Research Internship Program, a program that provides mentored, hands-on research experiences for undergraduate and graduate students.
From 2008-2012, Dr. McLean worked in the Division of Viral Diseases at CDC. She was involved in multiple studies and outbreak investigations for vaccine preventable diseases, served as a WHO consultant on polio eradication in Kenya, and served as the CDC secretariat for the Advisory Committee on Immunization Practices (ACIP) work group on measles, mumps, and rubella vaccine.

Research Interests

-Vaccine effectiveness, immunogencity, safety, policy, and promotion
-Measles, mumps, rubella (MMR)
-Human papillomavirus
-Infectious diseases
-Longitudinal cohorts

Select Publications

  • Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine. VACCINE. 2018 Feb 1;36(6):818-826.
    PubMed ID: 29317117
  • King JP, McLean HQ, Meece JK, Levine MZ, Spencer SM, Flannery B, Belongia EA. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season. VACCINE. 2018 Feb 21;36(9):1214-1219.
    PubMed ID: 29395525
  • King JP, McLean HQ, Belongia EA. Validation of Self-Reported Influenza Vaccination in the Current and Prior Season. Influenza Other Respir Viruses.. 2018 Jul 20;
    PubMed ID: 30028081
  • McLean HQ, Fiebelkorn AP, Ogee-Nwankwo A, Hao L, Coleman LA, Adebayo A, Icenogle JP. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults. VACCINE. 2018 Sep 11;36(38):5732-5737.
    PubMed ID: 30107992
  • Frost HM, McLean HQ, Chow BDW. Variability in Antibiotic Prescribing for Upper Respiratory Illnesses by Provider Specialty. J Pediatr. 2018 Sep 5;
    PubMed ID: 30195553
  • McLean HQ, Peterson SH, King JP, Meece JK, Belongia EA. School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015. Influenza Other Respi Viruses. 2017 May;11(3):220-229.
    PubMed ID: 27885805
  • Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines. 2017 Jul;16(7):1-14.
    PubMed ID: 28562111
  • McLean HQ, VanWormer JJ, Chow BDW, Birchmeier B, Vickers E, DeVries E, Meyer J, Moore J, McNeil MM, Stokley S, Gee J, Belongia EA. Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention. J Adolesc Health. 2017 Aug;61(2):252-258.
    PubMed ID: 28462786
  • McLean HQ, Caspard H, Griffin MR, Poehling KA, Gaglani M, Belongia EA, Talbot HK, Peters TR, Murthy K, Ambrose CS. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season. VACCINE. 2017 May 9;35(20):2685-2693.
    PubMed ID: 28408121
  • Van Wormer JJ, King JP, Gajewski A, McLean HQ, Belongia EA. Influenza and Workplace Productivity Loss in Working Adults. J Occup Environ Med. 2017 Dec;59(12):1135-1139.
    PubMed ID: 28759481
  • VanWormer JJ, Bendixsen CG, Vickers ER, Stokley S, McNeil MM, Gee J, Belongia EA, McLean HQ. Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents. BMC Public Health.. 2017 Oct 2;17(1):766.
    PubMed ID: 28969653
  • Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016 Aug;16(8):942-951.
    PubMed ID: 27061888
  • McLean HQ, Chow BD, VanWormer JJ, King JP, Belongia EA. Effect of Statin Use on Influenza Vaccine Effectiveness. J Infect Dis. 2016 Oct 15;214(8):1150-1158.
    PubMed ID: 27471318
  • McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman R, Nowalk M, Raviotta JM, Jackson ML, Jackson L, Ohmit SE, Petrie JG, Monto A, Meece JK, Thaker S, Thaker S, Clippard J, Spencer SM, Fry A, Belongia EA. Influenza Vaccine Effectiveness in the United States During 2012-13: Variable Protection by Age and Virus Type. JOURNAL OF INFECTIOUS DISEASES. 2015 May;211(10):1529-40.
    PubMed ID: 25406334
  • McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich T, Belongia EA. Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons. Clin Infect Dis.. 2014 Nov;59(10):1375-85.
    PubMed ID: 25270645
  • Kutty P, McLean HQ, Lawler J, Schulte C, Hudson J, Blog D, Wallace G. Risk Factors for Transmission of Mumps in a Highly Vaccinated Population in Orange County, New York, 2009-2010. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2014 Feb;33(2):121-5.
    PubMed ID: 23995590
  • McLean HQ, Meece JK, Belongia EA. Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness. VACCINE. 2014 Jan;32(4):453-7.
    PubMed ID: 24291201
  • McLean HQ, Fiebelkorn AParker, Temte JL, wallace GS. Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep.. 2013 Jun;62(RR-04):1-34.
    PubMed ID: 23760231
  • Marin M, Nguyen HQ, Langidrik J, Edwards R, Briand K, Papania M, Seward J, LeBaron CW. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. CLINICAL INFECTIOUS DISEASES. 2006 Feb;42(3):315-9.
    PubMed ID: 16392073
  • Nguyen HQ, Jumaan AO, Seward J. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. NEW ENGLAND JOURNAL OF MEDICINE. 2005 Feb;352(5):450-8.
    PubMed ID: 15689583
  • Marin M, Nguyen HQ, Keen J, Jumaan AO, Mellen P, Hayes E, Gensheimer K, Gunderman-King J, Seward J. Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003. PEDIATRICS. 2005 Apr;115(4):900-5.
    PubMed ID: 15805362